A group of researchers from Austria, Canada, Germany, and the U.S. have retracted a 2008 paper in the Journal of Immunology after being unable to verify the contents of some key figures.
Here’s the notice: Continue reading Immunology paper retracted because “documents were not archived with due diligence”
Michael Hertl, a leading dermatology researcher at Philipps-University Marburg, has been cleared of any wrongdoing in a case that spawned a retraction last year and two just-published retractions.
Felicitas Riedel, a legal officer for the university, tells Retraction Watch that the
…Committee for Scientific Misconduct of the Philipps-University Marburg closed the matter and submitted its results to the President of the University who in the meantime after examination consented with it.
The findings? Continue reading University clears leading dermatology lab head of misconduct as authors issue two corrections
The World Journal of Surgical Oncology has posted the retraction of a 2010 article by Italian researchers who lifted substantial parts of their text from a group that had published on the same topic seven years earlier.
The article, “Colon and rectal surgery for cancer without mechanical bowel preparation: one-center randomized prospective trial,” came from a group of surgical oncologists at San Martino Hospital in Genoa led by Stefano Scabini, who is listed in other publications as chief of the service.
According to the notice: Continue reading Authors retract “one-center” cancer study for plagiarizing from…another center
A group of researchers from Texas and Zimbabwe has lost a paper after they tried publishing it twice — first in the European Journal of Clinical Pharmacology, and then in the International Journal of Clinical Pharmacy.
Here’s the notice: Continue reading Study linking antidepressants to diabetes retracted when authors publish it twice
Perhaps fittingly in today’s age of sensitive feelings, the typical reaction to a retraction (per the notices, at least) is apology. But bliss?
Expert Opinion on Investigational Drugs has a new one in the annals of penitence. At issue is a 2010 paper titled “Horizon scanning for novel therapeutics for the treatment of prostate cancer,” by Dieletta Bianchini. Turns out the authors had published the same (or nearly so) paper two months earlier in a different journal. Here’s the notice: Continue reading Retraction for prostate cancer paper duplication leaves authors penitent, “happy”
The journal Group Dynamics: Theory, Research, and Practice is retracting a 2003 paper by psychologist Lawrence Sanna, who appears to have been fabricating his data. Sanna’s work, Retraction Watch readers may recall, came under the scrutiny of Uri Simonsohn, who also investigated Dirk Smeesters’ research.
Here’s the notice, which offers an impressive amount of back story as these things go: Continue reading “Invalid data” prompt retraction of another paper from psychologist Sanna
Last spring, we reported on the retraction in Clinical and Translational Allergy of a 2011 paper by researchers in Egypt and Finland after “severe problems in the data set” were uncovered. The notice cited an earlier study, from 2009, in Acta Paediatrica, that formed the basis for the subsequent trial.
At the time, the Acta Paediatrica paper still stood. No longer: Continue reading Allergy researchers lose second paper over “severe problems” with data
Diederik Stapel’s CV continues to crumble, with five more retractions for the disgraced Dutch social scientist who admitted to fabricating data in his studies.
The latest articles to fall appeared in the Personality and Social Psychology Bulletin, a Sage title, bringing Stapel’s total to 25 that we’re aware of so far: Continue reading A fistful of Stapels: Psych journal retracts five more from Dutch researcher, upping total to 25
Less than 24 hours after the publication of a study showing no link between XMRV, aka xenotropic murine leukemia-related virus, and chronic fatigue syndrome (CFS), the authors of a a study claiming a link between the virus and prostate cancer have has been retractedit. The move comes along with the publication of a new study showing that no such link exists.
Here’s the notice, from PLoS Pathogens: Continue reading Another XMRV shoe drops: PLoS Pathogens study linking prostate cancer to virus retracted
Could this really — and finally — be the end for the alleged link between XMRV, also known as xenotropic murine leukemia-related virus, to chronic fatigue syndrome (CFS)?
The title of the press release announcing a long-awaited study of the subject in mBio is blunt: “Viruses not to blame for chronic fatigue syndrome after all.” A quote in the release from Ian Lipkin, who led the study, is even more direct: Continue reading New study “puts…speculation to rest” about link between XMRV and chronic fatigue syndrome